New hope for boosting blood levels in sickle cell patients
Disease control
Not yet recruiting
This study is testing if adding a new drug called SIL-8301 (senicapoc) to standard sickle cell treatment can improve anemia and reduce disease complications. It will involve about 105 young adults (16-35) with a specific type of sickle cell disease who have low blood counts despi…
Phase: PHASE2 • Sponsor: Biossil Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC